JOURNAVX & SUZETRIGINE PAIN CLINIC

Revolutionary Pain Relief Solution

Journavx (suzetrigine) is a newly approved non-opioid pain medication developed by Vertex Pharmaceuticals. The U.S. Food and Drug Administration (FDA) approved it on January 30, 2025, for the treatment of moderate to severe acute pain in adults. Clinical trials have demonstrated that Journavx provides pain relief comparable to traditional opioid-acetaminophen combination pills, such as hydrocodone/acetaminophen, but with fewer side effects. The approval of Journavx represents a significant advancement in pain management, offering a non-opioid alternative for acute pain relief..

black and brown leather padded tub sofa

Journavx: First non-opioid for acute pain management.

Trusted by healthcare professionals worldwide.

★★★★★

Innovative Pain Management Solutions

At Suzetrigine Clinic, we offer Journavx, a groundbreaking non-opioid analgesic designed to effectively manage moderate to severe acute pain in adults, targeting pain at its source.

suzetrigine doctor
suzetrigine doctor
Life-changing pain relief experience.
"

Pain Management Solutions

Introducing Journavx, first-in-class non-opioid treatment for moderate to severe acute pain.

Innovative Pain Relief

Journavx targets pain pathways, offering effective acute pain management without opioids.

Acute Pain Treatment

Experience cutting-edge medication designed specifically for acute pain related to tissue injuries.

Expert Pain Care

Our clinic provides personalized pain relief strategies using the latest advancements in medicine.

How it works

Pick up your medication at your local pharmacy

suzetrigine appointment
suzetrigine appointment
suzetrigine Doctor
suzetrigine Doctor
suzetrigine pharmacy
suzetrigine pharmacy

Pricing

New Patients $145

Established patients $135

About suzetrigine

Suzetrigine, marketed under the brand name JOURNAVX™, is a groundbreaking medication recently approved by the FDA for the treatment of moderate-to-severe acute pain in adults. Developed by Vertex Pharmaceuticals, suzetrigine represents a first-in-class therapy, offering a novel approach to pain management.

Understanding Suzetrigine

Suzetrigine is a potent and selective inhibitor of the NaV1.8 sodium channel, which plays a crucial role in transmitting pain signals in the nervous system. By targeting this specific channel, suzetrigine effectively reduces pain without the risks associated with traditional opioid medications.

Dosage and Administration

The recommended starting dose of JOURNAVX™ is 100 mg taken orally on an empty stomach, at least one hour before or two hours after food. Following this initial dose, patients should take 50 mg every 12 hours, with or without food. It's essential to follow the prescribed dosing schedule and consult with a healthcare provider for personalized guidance.

Safety and Side Effects

Clinical trials have demonstrated that suzetrigine is generally well-tolerated. Common side effects include nausea and vomiting. Patients are advised to discuss any adverse reactions with their healthcare provider to ensure safe and effective use.

Accessing Suzetrigine Through Telehealth Services

In today's digital age, obtaining prescriptions for medications like suzetrigine has become more accessible through telehealth platforms. Telehealth services allow patients to consult with healthcare providers remotely, making it convenient to receive medical advice and prescriptions without visiting a clinic in person.

Benefits of Telehealth for Pain Management

  • Convenience: Schedule appointments without the need to travel.

  • Accessibility: Access to specialists who may not be available locally.

  • Efficiency: Reduced waiting times and streamlined consultations.

For residents in McDonough, Georgia, several telehealth options are available:

Finding Pain Management Specialists Near You

If you prefer in-person consultations, and its surrounding areas offer several reputable pain management clinics:

Conclusion

Suzetrigine (JOURNAVX™) offers a promising new avenue for managing moderate-to-severe acute pain without the drawbacks of traditional opioids. With the rise of telehealth services, obtaining a prescription has become more convenient, allowing patients to consult with healthcare providers from the comfort of their homes. Whether through telehealth platforms or in-person visits, have access to a range of options to manage their pain effectively.

Customer Reviews

See how Journavx has transformed pain relief for our users.

Journavx changed my life, relieving pain from surgery effectively and quickly.

Lisa R.
A naloxone injection device and its packaging are displayed. The device is red with a gray base and housed in a gray plastic case. The packaging is a blue and white box with branding and dosage information prominently visible. Additional instructional materials are included inside the case.
A naloxone injection device and its packaging are displayed. The device is red with a gray base and housed in a gray plastic case. The packaging is a blue and white box with branding and dosage information prominently visible. Additional instructional materials are included inside the case.

New York

After using Journavx, my pain significantly decreased, allowing me to return to daily activities sooner than expected.

Two jars labeled 'Pain Relief CBD Salve' are placed on an orange surface, accompanied by a shadow of a decorative palm leaf. The larger jar is on the left, while the smaller one is on the right. The backdrop is a gradient of warm yellow shades, conveying a natural and organic ambiance.
Two jars labeled 'Pain Relief CBD Salve' are placed on an orange surface, accompanied by a shadow of a decorative palm leaf. The larger jar is on the left, while the smaller one is on the right. The backdrop is a gradient of warm yellow shades, conveying a natural and organic ambiance.
John D.

Los Angeles

★★★★★
★★★★★